The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hematopoietic Stem Cells (HSCs) Market Research Report 2025
Synopsis
The global Hematopoietic Stem Cells (HSCs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs).
Report Scope
The Hematopoietic Stem Cells (HSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematopoietic Stem Cells (HSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematopoietic Stem Cells (HSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Segment by Type
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Segment by Application
Blood System Diseases
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Hematopoietic Stem Cells (HSCs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells (HSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells (HSCs).
Report Scope
The Hematopoietic Stem Cells (HSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematopoietic Stem Cells (HSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematopoietic Stem Cells (HSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology
Segment by Type
Leukocyte
Lymphocytes
Red Blood Cells
Platelets
Segment by Application
Blood System Diseases
Autoimmune Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematopoietic Stem Cells (HSCs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Leukocyte
1.2.3 Lymphocytes
1.2.4 Red Blood Cells
1.2.5 Platelets
1.3 Market by Application
1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2019-2030)
2.2 Hematopoietic Stem Cells (HSCs) Growth Trends by Region
2.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2019-2024)
2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2025-2030)
2.3 Hematopoietic Stem Cells (HSCs) Market Dynamics
2.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers
2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue
3.1.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue (2019-2024)
3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2019-2024)
3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematopoietic Stem Cells (HSCs) Revenue
3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio
3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2023
3.5 Hematopoietic Stem Cells (HSCs) Key Players Head office and Area Served
3.6 Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service
3.7 Date of Enter into Hematopoietic Stem Cells (HSCs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2019-2024)
4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2025-2030)
5 Hematopoietic Stem Cells (HSCs) Breakdown Data by Application
5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2019-2024)
5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2019-2030)
6.2 North America Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2019-2024)
6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2019-2030)
7.2 Europe Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2019-2024)
7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size (2019-2030)
8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2019-2024)
8.4 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size (2019-2030)
9.2 Latin America Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2019-2024)
9.4 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size (2019-2030)
10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2019-2024)
10.4 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kite Pharma Inc.
11.1.1 Kite Pharma Inc. Company Detail
11.1.2 Kite Pharma Inc. Business Overview
11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.1.5 Kite Pharma Inc. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PromoCell
11.3.1 PromoCell Company Detail
11.3.2 PromoCell Business Overview
11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction
11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.3.5 PromoCell Recent Development
11.4 CellGenix Technologie Transfer GmbH
11.4.1 CellGenix Technologie Transfer GmbH Company Detail
11.4.2 CellGenix Technologie Transfer GmbH Business Overview
11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction
11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.4.5 CellGenix Technologie Transfer GmbH Recent Development
11.5 Cesca Therapeutics Inc.
11.5.1 Cesca Therapeutics Inc. Company Detail
11.5.2 Cesca Therapeutics Inc. Business Overview
11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.5.5 Cesca Therapeutics Inc. Recent Development
11.6 R&D Systems
11.6.1 R&D Systems Company Detail
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction
11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.6.5 R&D Systems Recent Development
11.7 Genlantis
11.7.1 Genlantis Company Detail
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction
11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.7.5 Genlantis Recent Development
11.8 Lonza Group Ltd.
11.8.1 Lonza Group Ltd. Company Detail
11.8.2 Lonza Group Ltd. Business Overview
11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction
11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.8.5 Lonza Group Ltd. Recent Development
11.9 TiGenix N.V.
11.9.1 TiGenix N.V. Company Detail
11.9.2 TiGenix N.V. Business Overview
11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction
11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.9.5 TiGenix N.V. Recent Development
11.10 ScienCell Research Laboratories
11.10.1 ScienCell Research Laboratories Company Detail
11.10.2 ScienCell Research Laboratories Business Overview
11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction
11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.10.5 ScienCell Research Laboratories Recent Development
11.11 China Cord Blood Corporation
11.11.1 China Cord Blood Corporation Company Detail
11.11.2 China Cord Blood Corporation Business Overview
11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction
11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.11.5 China Cord Blood Corporation Recent Development
11.12 Vcanbio
11.12.1 Vcanbio Company Detail
11.12.2 Vcanbio Business Overview
11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction
11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.12.5 Vcanbio Recent Development
11.13 Boyalife
11.13.1 Boyalife Company Detail
11.13.2 Boyalife Business Overview
11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction
11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.13.5 Boyalife Recent Development
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Detail
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction
11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2019-2024)
11.14.5 Beike Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
